Zimmer Biomet received an additional FDA 510(k) clearance for the Persona® Revision Knee. Initial U.S. launch will commence in coming weeks; full launch is slated for 2020. This revision model completes the company’s portfolio of Persona patient-personalized designs. Persona Revision received its first 510(k) clearance in 4Q18.
Persona Revision features Zimmer Biomet’s Trabecular Metal™ porous biomaterial and the Vivacit-E® Highly Crosslinked Polyethylene (HXPE) bearing surface. Persona knees are compatible with the company’s ROSA® Knee robot, along with Vanguard® and NexGen® systems.
“Persona Revision completes Zimmer Biomet’s flagship Persona knee system and enhances our ecosystem of customer-centric solutions that address the needs of our customers and improve patient outcomes,” said Ivan Tornos, Zimmer Biomet’s Group President of Global Orthopedics. “The highly-anticipated release of Persona Revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient’s unique requirements.”
Zimmer Biomet received an additional FDA 510(k) clearance for the Persona® Revision Knee. Initial U.S. launch will commence in coming weeks; full launch is slated for 2020. This revision model completes the company's portfolio of Persona patient-personalized designs. Persona Revision received its first 510(k) clearance in 4Q18.
Persona...
Zimmer Biomet received an additional FDA 510(k) clearance for the Persona® Revision Knee. Initial U.S. launch will commence in coming weeks; full launch is slated for 2020. This revision model completes the company’s portfolio of Persona patient-personalized designs. Persona Revision received its first 510(k) clearance in 4Q18.
Persona Revision features Zimmer Biomet’s Trabecular Metal™ porous biomaterial and the Vivacit-E® Highly Crosslinked Polyethylene (HXPE) bearing surface. Persona knees are compatible with the company’s ROSA® Knee robot, along with Vanguard® and NexGen® systems.
“Persona Revision completes Zimmer Biomet’s flagship Persona knee system and enhances our ecosystem of customer-centric solutions that address the needs of our customers and improve patient outcomes,” said Ivan Tornos, Zimmer Biomet’s Group President of Global Orthopedics. “The highly-anticipated release of Persona Revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient’s unique requirements.”
Copy to clipboard 
